Navigation Links
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Date:9/5/2007

p were 15.6 percent for women versus 13.2 percent for men (p=0.214), while MACE rate in BMS group were 24.0 percent for women versus 21.7 percent for men (p=0.332).

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance, competitive offerings, procedural volume, overall market size and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
2. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
3. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
4. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
5. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 PositiveID Corp. (OTCQB: PSID), based ... is an emerging player in the bio-threat detection ... detection and rapid medical testing. The Company,s proprietary ... Autonomous Networked Detector), was developed under contract with ... & Technology directorate, and $30 million of contract ...
(Date:7/23/2014)... , July 23, 2014  Researchers from the ... calcium elevates calcium levels too high, 1 ... other health problems. Women close to menopause ... vitamin D to prevent diseases such as osteoporosis, to ... recommend that women determine how much calcium they typically ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... DIEGO , Feb. 16 PatientSafe Solutions, Inc., ... today announced the executive management team tasked with executing the ... safety in healthcare.  James M. Sweeney, Chairman and Chief Executive ... successful healthcare product and service companies including Caremark, Bridge Medical ...
... Pa. , Feb. 16 On February 23 ... Virtual Healthcare IT Conferences. The conference, accessed at www.siemens.com/virtual-ARRA ... on achieving Meaningful Use of electronic health records, tied to the HITECH ... (ARRA), and how health IT technology can help propel organizations to exceptional ...
Cached Medicine Technology:PatientSafe Solutions, Inc. Announces Management Team 2PatientSafe Solutions, Inc. Announces Management Team 3Siemens Hosts First In a Series of Free Virtual Healthcare IT Conferences 2Siemens Hosts First In a Series of Free Virtual Healthcare IT Conferences 3
(Date:7/23/2014)... 2014 Four hospitals affiliated with the ... the latest ranking of the country’s best hospitals by ... online today and slated for publication in August, the ... Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and West ... clinical specialties. , “There is no higher ...
(Date:7/23/2014)... Kathleen Doheny HealthDay Reporter ... surgery appears to have an additional side benefit -- ... to a new study. The study found that ... reported having incontinence prior to the procedure. After surgery, ... improved or disappeared, said study researcher Dr. Leslee Subak, ...
(Date:7/23/2014)... -- For patients infected with both HIV and hepatitis ... viruses, a small study suggests. Researchers said doctors ... people with the two diseases. "The findings ... important role in the management of individuals with [hepatitis ... Sherman, a professor of medicine at the University of ...
(Date:7/23/2014)... a massive effort to catalog the molecular causes ... Cancer Institute, have identified four subtypes of tumors ... They say the new classification promises to advance ... third-leading cancer killer worldwide. , In a report ... Genome Atlas Research Network said they analyzed 295 ...
(Date:7/23/2014)... cancer genes have been focused on the regions of ... in the form of amino acids thus proteins. But ... or activator which controls the expression and activity of ... of the role exerted such DNA fragment in tumor ... Nature in collaboration with the group of Manel ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... ... ... ... ...
... ... ... ... ...
... ... Weight-Control Formulas: Licorice Flavonoid Oil. Licorice Flavonoid Oil is a “nutrigenomic” supplement, meaning it ... ... -- Nutrigenomics is the study of how foods affect genetics and how individual genetic ...
... kept cancer from spreading in mice, researchers say , FRIDAY, ... the spread of the cancer in mice, a new study ... mice with breast cancer. Both involve applying a cold probe ... 30 seconds) of the tumor, while the other takes a ...
... ... ... , ... , , ...
... ... ... ... ...
Cached Medicine News:Health News:Donations Sought for Chilean Relief, Children's Clinics 2Health News:Donations Sought for Chilean Relief, Children's Clinics 3Health News:Donations Sought for Chilean Relief, Children's Clinics 4Health News:Donations Sought for Chilean Relief, Children's Clinics 5Health News:Donations Sought for Chilean Relief, Children's Clinics 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 2Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 3Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 4Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 5Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 7Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 8Health News:Licorice Flavonoid Oil with Glavonoid™ Added to the Swanson Health Products' Swanson Best Weight-Control Formulas 2Health News:Freezing Technique May Stop Breast Cancer 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 3Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 2Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 3Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 5
... "mobile operating table" literally! The Alphastar 1132 with ... a general purpose operating table - is as ... a cable connected hand control, an IR-hand control ... is a control panel at the top of ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
... The state-of-the-art Opus II urology imaging table ... enhanced patient access, exceptional imaging and advanced ... has the smallest footprint in the industry ... anesthesiologist and can be changed to either ...
Inquire...
Medicine Products: